Chongqing Pharscin Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 6.77% vs 7.84% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 327.56% vs -181.41% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "209.90",
          "val2": "196.60",
          "chgp": "6.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.40",
          "val2": "13.70",
          "chgp": "121.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.90",
          "val2": "-12.70",
          "chgp": "327.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "145.00%",
          "val2": "-47.50%",
          "chgp": "19.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.71% vs 12.08% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -28.03% vs 134.56% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "813.90",
          "val2": "762.70",
          "chgp": "6.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "141.10",
          "val2": "148.20",
          "chgp": "-4.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.60",
          "val2": "7.60",
          "chgp": "26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "55.20",
          "val2": "76.70",
          "chgp": "-28.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "64.10%",
          "val2": "81.50%",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

209.90

196.60

6.77%

Operating Profit (PBDIT) excl Other Income

30.40

13.70

121.90%

Interest

0.10

0.00

Exceptional Items

0.60

0.30

100.00%

Consolidate Net Profit

28.90

-12.70

327.56%

Operating Profit Margin (Excl OI)

145.00%

-47.50%

19.25%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 6.77% vs 7.84% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 327.56% vs -181.41% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

813.90

762.70

6.71%

Operating Profit (PBDIT) excl Other Income

141.10

148.20

-4.79%

Interest

0.00

0.00

Exceptional Items

9.60

7.60

26.32%

Consolidate Net Profit

55.20

76.70

-28.03%

Operating Profit Margin (Excl OI)

64.10%

81.50%

-1.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.71% vs 12.08% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -28.03% vs 134.56% in Dec 2024

All Annual Results